Navigation Links
Hospira to Present at J.P. Morgan's 27th Annual Healthcare Conference January 14
Date:12/29/2008

LAKE FOREST, Ill., Dec. 29 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that Christopher B. Begley, chairman and chief executive officer, and Thomas E. Werner, senior vice president, Finance, and chief financial officer, will make a formal presentation at J.P. Morgan's 27th Annual Healthcare Conference on Wednesday, Jan. 14, 2009, at The Westin St. Francis Hotel in San Francisco.

The presentation is scheduled to begin at 10 a.m. Pacific time on Wednesday, Jan. 14, 2009. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the audiocast. The slides accompanying the presentation will be available on the Hospira Web site. A replay of the webcast will be available on the Hospira Web site approximately 24 hours after the live presentation.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
2. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
3. Hospira Reports Third-Quarter 2007 Results
4. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
5. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
6. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
7. Hospira Launches Generic Irinotecan Injection
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
10. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
11. Hospira Acquires Sculptor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...abbits implanted with new cells regained sexual fu...9 (HealthDay News) -- Researchers were able to res...es by growing new penile tissue in the lab and imp...an application is a ways off, researchers say the ...ectile dysfunction in men. , "We were able to s...
(Date:11/9/2009)... Course, to be Offered in ...sic Toolkit , Cambridge, ... of Physicians for Human Rights (PHR) first inspec...ghanistan , he realized he would need a team of ex...cumenting the site properly was a key first step i...
(Date:11/9/2009)..., March of Dimes Names 2010 National Ambassad...USNewswire/ -- Joshua Hoffman of Weston, Fla., was...ans that doctors could not say whether he would su...ar. Today, the 6-year-old was named March of Dimes...lanie Hoffman, recalls, "My first minutes of mothe...
(Date:11/9/2009)...tudy didn,t answer question of why this is so, how...s) -- After a lumpectomy, women with very dense br...he affected breast, a new study shows. , Breast... risk of developing breast cancer, and experts hav...sociated with an increased risk of cancer recurren...
(Date:11/9/2009)..., PITTSFIELD, Maine, Nov. 9 At ...nts in Maine are increasingly concerned about find...ompetitive Medicare option for 2010. ,, The Tod... (PPO) Medicare Advantage plan provides a cost-eff...edicare or a Medicare Supplement plan. People wit...
Breaking Medicine News(10 mins):Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 2Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 3Health News:Physicians for Human Rights Offers Training in Crime Scene Documentation 4Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2
... Terri Milen of TEM Counseling LLC lau...terrimilen.com [Online Counseling via video/phone...] to clients in the comfort of their own home or o...which requires clients to make room for another ap...
...no sample traced back to Mexican farm, FDA announc...- Almost a week after uncovering the first big cl...lth officials announced Friday that tainted jalape...s grown in the United States, but warned consumers...
...o discuss second quarter financial results -, LAV... Inc. (TSX: DDS;,NASDAQ: DDSS) today announced tha... 8 at 8:30 a.m. (ET) to discuss its second quarter...o access the conference call by telephone, dial 41...
... cleaning products reduces lung function, increase...uly 25 (HealthDay News) -- A clean, fresh-smelling...ng on what type of cleaning and air freshening pro...called 1,4 dicholorobenzene (1,4 DCB), can reduce ...
...5 BeaconEquity.com announces the,availability of ...ors can view all of the daily trading notes for fr...y,s Trade Alerts include: DUSA Pharmaceuticals Inc...daq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )., J...
...Marketing Exclusivity Begins -, CORONA, Calif., J..., a leading specialty pharmaceutical,company, anno...ercial,shipment of its Omeprazole Delayed-Release ...ting exclusivity for being the,first to file an AN...
Other Medicine News:Health News:Online Counseling and Life Coaching Practice Launches New Website 2Health News:Mexican Peppers ID'd as Salmonella Culprits 2Health News:Mexican Peppers ID'd as Salmonella Culprits 3Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
(Date:11/9/2009)..., ROCKVILLE, Md., Nov. 9 OriGene T...of Technology in Sweden has adopted its VERIFY Tag...uman Protein Atlas program. This program is funded...s set up to explore the human proteome systematica...igh quality mono-specific antibodies in a high thr...
(Date:11/9/2009)..., POTOMAC FALLS, Va., Nov. 9 TessA...roarray-based applications, announces the launch o...ting of the mutations that underlie human heredita...ise in microarray-based resequencing with novel nu...sis software enables screening for all targeted mu...
(Date:11/9/2009)..., TOWN OF HEMPSTEAD, N.Y., Nov. 9 /PRNewswire/ --...lice officers and other rescue workers came togeth...ity. Merrick firefighter Brian McCauley was one of...o save his own life. ,, Only in his late 30s, M...undergone surgery and extensive chemotherapy treat...
Breaking Medicine Technology:Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2TessArae Delivers Lower Cost Option to Genetic Testing Market 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 2The SCOOTER Store Surprises 9/11 First Responder & Merrick Firefighter With Power Chair 3Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 1Pausing Hormone Therapy Doesnt Cut Mammogram Recalls 47850 2Synthetech Announces Fiscal 2009 Results 47845 1Synthetech Announces Fiscal 2009 Results 47845 2Synthetech Announces Fiscal 2009 Results 47845 3Synthetech Announces Fiscal 2009 Results 47845 4Synthetech Announces Fiscal 2009 Results 47845 5Synthetech Announces Fiscal 2009 Results 47845 6Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 1Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 2Consumer Watchdog Praises Insurance Commissioner Poizner for Health Insurance Rescission Rules Pans Schwarzenegger Administration for Failure to Regu 47842 3
... Potency and Slow Dissociation from HCV,Protease ,...ia COMTEX News,Network/ -- InterMune, Inc. (Nasdaq...e company,s Hepatitis C virus (HCV) NS3/4A,proteas... of the,Digestive Disease Week (DDW) meeting being...tudy (DDW abstract #M1816) examined,ITMN-191 poten...
...ATION WITH DIURETIC ACCEPTED FOR REVIEW BY,FDA- , ...07 -,Speedel (SWX: SPPN) today welcomed the signif...aliskiren, Tekturna/Rasliez[1]),presented by inves... Exposition of the American Society of Hypertensio... the favourable safety and,efficacy profile, as we...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 4InterMune Presents Research on ITMN-191 in Hepatitis C at Digestive,Disease Week Meeting 5New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 2New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 3New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 4New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 5New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 6New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 7New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 8New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 9New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 10New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard,Therapy in Treatment of Hypertension 11
Liquichek Reticulocyte Control
Liquichek ToRCH Plus IgM Controls
Liquichek Seroconversion Panels
Amplichek CT/GC Controls
Medicine Products: